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a  b  s  t  r  a  c  t
Alginates  are  widely  used  in the  food  and  medical  industries,  including  as  a Gastro-Oesophagul  Reﬂux
treatment.  This  work  investigates  the  inhibitory  effects  of alginate  on  the  reﬂux  aggressors  trypsin  and
pepsin  and  the  role  of  alginate-substrate  binding,  pH and  alginate  structure  on inhibition.  Alginates  were
shown  to reduce  pepsin  activity  by up to 53.9%  (±9.5SD)  in  vitro.  Strong  positive  correlation  between
alginate  mannuronate  residue  frequency  and levels  of pepsin  inhibition  was  observed.  Limited  inhibitioneywords:
lginate
epsin
rypsin
roteolysis
odel gut system
of  trypsin  was  shown.  Viscometric  observations  of pH  dependent  interactions  between  alginate  and
protein  suggest  a mechanism  whereby  pH  dependent  ionic  interactions  reduce  substrate  availability  to
enzyme  at acidic  pH. To  understand  how  dietary  protein  digestion  is  affected  by alginate,  proteolytic
digestion  was investigated  in an  in  vitro  model  of  the  upper  digestive  tract. Signiﬁcant  inhibition  of
proteolysis  was  shown  in  the gastric  phase  of digestion,  but  not  the  small  intestinal  phase.
© 2015  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Alginates have previously been shown to inhibit pepsin activity
n vitro, Sunderland, Dettmar, and Pearson (2000) showed alginates
ould inhibit pepsin activity by 52% in vitro. Strugala, Kennington,
ampbell, Skjak-Braek, and Dettmar (2005), showed signiﬁcant
orrelations between alginate structure and levels of inhibition,
ith high frequency of mannuronic acid residues (F[M]) alginates
ending to inhibit better than those high in guluronic acid residues
F[G]). However the mechanism of pepsin inhibition is poorly
nderstood, as is how alginate effects dietary proteolysis and the
ctivity of small-intestinal proteases such as trypsin.
Pepsin has been shown to be a major aggressor in GORD (Gastro-
esophagul Reﬂux disease) (Strugala, Avis, Jolliffe, Johnstone, &
ettmar, 2009) with in vivo addition of pepsin to the oesophagus
esulting in reﬂux-like oesophagitis in animal models (Goldberg,
odds, Gee, Montgomery, & Zboralske, 1969). Alginates are used in
he treatment of reﬂux (Sunderland et al., 2000). The primary mech-
nism of alginate treatment of reﬂux is the formation of an alginate
aft upon coming into contact with stomach acid; sodium or
otassium bicarbonate in the formulation releases carbon dioxide
hich becomes trapped in the gel as a foam, allowing the alginate
∗ Corresponding author. Tel.: +44 0191 208 5013; fax: +44 0191 208 7424.
E-mail address: peter.chater@ncl.ac.uk (P.I. Chater).
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144-8617/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article
.0/).license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
acid-gel raft to ﬂoat on the top of the stomach contents and create a
physical barrier to reﬂuxate (Dettmar, Sykes, Little, & Bryan, 2006;
Sengupta, Shah, & Shah, 2015). The inhibitory action of alginate on
pepsin is thought to be a secondary mechanism for the anti-reﬂux
activity of alginate based agents (Strugala et al., 2009).
The damaging potential of the pancreatic protease trypsin has
also been demonstrated in gastroduodenal reﬂuxate. With the use
of proton pump inhibitors in the treatment of reﬂux disease, gas-
tric pH becomes elevated. During a gastro-duodenal reﬂux event, if
trypsin passes through the stomach at pH 4.0 or above (or rapidly
through at low pH of 2 or less) it can retain proteolytic activity
and cause damage (Pearson et al., 2011). We  therefore seek to
investigate the effects of alginate on trypsin activity and examine
a potential role of alginate in the management of trypsin mediated
damage in gastro-duodenal reﬂux.
Furthermore, alginates are widely used in the food and medi-
cal industries and have a range of bioactive properties, as reviewed
elsewhere (Brownlee et al., 2005). Alginates have been shown to
be potent inhibitors of pancreatic lipase activity and are being
investigated as a potential tool for the management of obesity
(Balasubramaniam et al., 2013). It is therefore important to under-
stand the secondary effects alginate may  have on protein digestion.In this work we therefore seek to investigate the inhibitory
action of alginate on trypsin and pepsin in vitro and to charac-
terise the effects of varying alginate structure on any inhibition
observed. We  also investigate the pH dependency of viscometric
 under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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nteractions between alginate and protein substrates. Finally the
nhibitory effects of alginate on protein digestion are investigated
n a model gut system.
. Methods
.1. Materials
All alginate samples tested were kindly supplied by FMC
iopolymer and Technostics Ltd (Hull, UK). Bovine serum albu-
in  (BSA) was purchased from VWR  Jencons. Unless otherwise
tated, all other chemicals and reagents were purchased from
igma–Aldrich (Poole, UK). The structures of the alginate samples
ere characterised by 13C NMR  neighbour diad analysis and the
ull characteristics of all samples are shown in Table 1.
.2. N-Terminal proteolytic assay
Proteolytic activity was determined using an adapted version of
he N-terminal assay developed by Lin, Means, and Feeney (1969)
nd modiﬁed by Hutton, Allen, Pearson, Ward, and Venables (1986).
he activity assay was scaled down to a 96-well microplate as
eported in Ali, Parikh, Chater and Pearson (2013). Alginate was  pre-
ared in 0.05 M phosphate (pH 2.5) as alginate was shown to alter
he pH of the reaction mixture when made up in distilled water as
er Strugala et al. (2005).
For pepsin activity, 10 g/ml pepsin (prepared 10 min  prior to
ssay) and 10 mg/ml  succinyl albumin were each made up in 0.05 M
hosphate buffer at pH 2.5. In order to prevent precipitation, algi-
ate samples were prepared at 10 mg/ml  in the basic side of the
uffer and then diluted at a 1:1 ratio with the acidic side of the
uffer to give a concentration of 5 mg/ml  in 0.05 M phosphate
uffer. Trinitrobenzosulfonic acid (TNBS) was prepared at 2 l/ml
n deionised water. Sodium bicarbonate was prepared 10% w/v.
entosan polysulphate (SP54) at 5 mg/ml  was  used as a positive
nhibition control (Bianchi & Cook, 1964; Cook & Drill, 1967).
For trypsin activity assay, 5 g/ml trypsin (prepared 10 min
rior to assay) and 10 mg/ml  succinyl albumin were each made
p in 0.066 mM Sorensen’s phosphate buffer at pH 7. Alginate sam-
les were prepared at 5 mg/ml  in 0.066 M Sorensen’s phosphate
uffer. Trinitrobenzosulfonic acid (TNBS) and sodium bicarbonate
ere prepared as above. Soybean trypsin inhibitor was used as a
ositive inhibition control.
Eighteen alginates were tested for their ability to inhibit pepsin
nd trypsin activity. All alginate samples were tested at three con-
entrations; 5, 2.5 and 1.25 mg/ml. This gave concentrations in the
eaction mixture of 1.36, 0.68 and 0.34 mg/ml, respectively.
Thirty microlitres of alginate sample was pre-incubated with
0 l succinyl albumin substrate for 60 min  on a shaker. At T0 30 l
nzyme solution or buffer blank was added as appropriate and the
late was incubated for 30 min  at 37 ◦C. After 30 min, 50 l sodium
icarbonate and 50 l TNBS was added, mixed and the plate was
ncubated for 15 min  at 55 ◦C. At T45, 50 l SDS (10% w/v) and 50 l
 M hydrochloric acid were added and the plate was left to stand
ntil all wells had stopped effervescing, and absorbance was mea-
ured at 340 nm using a Biotek 96 well microplate reader (Elx808
iotek, Bedfordshire, UK).To calculate percentage pepsin inhibition the following formula
as used:
Precentage pepsin inhibition
= polymer sample − sample control
pepsin control − background control × 100
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Four of the 19 samples had small but signiﬁcant effects on
trypsin activity. FMC  5 was  the only alginate sample to show
a signiﬁcant inhibition of trypsin activity at all three concentra-
tions, 10.4% ± 2 at 5 mg/ml, 7.5% ± 2.5 at 2.5 mg/ml  and 7.9% ± 2.7
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.3. Alginate-protein viscosity interactions
Alginates were made up at 2.5 mg/ml  as control or with casein
r BSA at 10 mg/ml  in deionised water and titrated across the pH
.5–9 using HCl and NaOH. Samples were incubated at room tem-
erature for 30 min  and then left to stand for a further 30 min  to
llow precipitate to settle. Two millilitres of the sample supernatent
as decanted, and viscosity was measured.
Sample viscosity was measured using a cup and bob viscometer
Contraves, Switzerland). All samples were tested in triplicate and
elative viscosity (rel) was  calculated from percentage deﬂection.
peciﬁc viscosity (sp) was  then calculated from relative viscosity.
.4. Model gut
Model gut analysis was conducted in an artiﬁcial simulation of
he upper GI tract. The system was set up and solutions prepared as
escribed in Houghton et al. (2014). Analysis of protein digestion
as conducted as described below.
.4.1. Protein digestion
In order to distinguish effects on protein digestion from the
astric and pancreatic phases of digestion, gastric and pancreatic
roteolysis assays are described separately.
.4.2. Gastric protein digestion
In the gastric phase 0.5 g BSA is added to the salivary diluents
t T[−10] and the assay was run until the end of the gastric phase at
[60].
.4.3. Small intestinal protein digestion
One gram of BSA was added to synthetic saliva at T[−10] and
astric pepsin was omitted from the gastric diluent to prevent any
rotein digestion in the gastric phase.
.4.4. Background control
For background controls 10 ml  synthetic saliva was prepared
ithout substrate BSA.
.4.5. Proteolysis analysis
Undigested polypeptides were removed from samples by
richloroacetic acid (TCA) precipitation and centrifugation. Pro-
ein digestion was measured by assaying amino acids and short
ligopeptides remaining in the supernatant with the Pierce BCA
otal Protein assay kit.
The Pierce BCA assay is known to under-report amino acid
nd oligo-peptide metabolites of protein digestion (Wiechelman,
raun, & Fitzpatrick, 1988). The authors observed that 37.76% of
SA is reported in the BCA assay after exhaustive overnight diges-
ion with pepsin at pH2 (1 mg/ml) and trypsin at pH7 (1 mg/ml)
t 37 ◦C (this can be corrected for by a factor of 2.65). It was  also
hown that due to bile binding of protein metabolites, only 60.33%
f digested protein is detected (this can be corrected for by a fac-
or of 1.66 in the small intestinal phase, resulting in a correction
actor of 4.4 in the small intestinal phase to correct for both the
nder-reporting and bile binding effects) (data not included).
.5. Statistical analysis
All data were analysed using GraphPad Prism 4 statistical soft-
are. Statistical analyses of levels of inhibition compared to control
as done using a Student’s t-test with a signiﬁcance level of p = 0.05.
ll samples were tested in triplicate and are reported as mean and
tandard deviation.lymers 131 (2015) 142–151
3. Results
3.1. In vitro protease activity assay
At pH 2.5, all alginates tested showed the ability to inhibit pepsin
activity at the highest concentration of 5 mg/ml  (Table 1). Aver-
age pepsin activity was  reduced by 6.8% ± 6.1 SD at 1.25 mg/ml,
by 18.3% ± 7.5 at 2.5 mg/ml  and by 31.9% ± 6.1 at 5 mg/ml. The
strongest inhibitor at 5 mg/ml  was  H120L which has an F[G] of
0.45 and reduced pepsin activity to 53.9% ± 9.5 of control activ-
ity. The weakest inhibitor at 5 mg/ml  was  FMC3 which has an
F[G] of 0.68 and reduced pepsin activity to 88.6% ± 10.6 SD of
control activity. Full characteristics for alginates are shown in
Table 1.
Alginate structure was correlated with percentage pepsin inhi-
bition. A signiﬁcant negative correlation was  shown between
pepsin inhibition and alginate F[G] at 5 mg/ml  (Fig. 1). This indi-
cates that at 5 mg/ml, an increasing proportion of mannuronic
acid residues, and decreasing proportion of guluronic acid residues
yielded higher levels of pepsin inhibition.
The structure and biophysical properties of alginates are not just
dictated by F[G] frequency, but also by the arrangement of contigu-
ous blocks of M and G residues. Levels of pepsin inhibition were
compared against the frequency of the structural patterns; F[M],
F[GG], F[MM], F[GGG], F[MGM] and F[GM/MG] and also against
n(G > 1), the G-block length (Fig. 2). Similar signiﬁcant relationships
between structure and inhibition were observed, where higher lev-
els of mannuronic acid brought about signiﬁcantly higher levels
of pepsin inhibition. As the G-block length increases, a signiﬁcant
reduction in the inhibition of pepsin was observed, showing a neg-
ative correlation between inhibition and n(G > 1).
Molecular weight data was  only available for eight of the algi-
nates tested. Alginates can vary greatly in molecular weight and
the Technostics alginates used in this study ranged from 34,700 to
387,000 Da. However no signiﬁcant correlation between molecular
weight and pepsin inhibition could be demonstrated as shown in
(data not shown).Fig. 1. Correlation of alginate G-residue frequency (F[G]) and level of pepsin inhibi-
tion with 5 mg/ml alginate. Pepsin activity is shown as a percentage of control pepsin
activity. The error bars show the standard deviation of six replicates (n = 6). The line
of  best ﬁt indicates a negative correlation which is signiﬁcant with a Spearman r
value of −0.7789 and a p value of 0.0001.
P.I. Chater et al. / Carbohydrate Polymers 131 (2015) 142–151 145
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iig. 2. Correlation of alginate structural patterns; (a) F[M], (b) F[GG], (c) F[GGG], (d
ith  5 mg/ml  alginate. Pepsin activity is shown as a percentage of control pepsin ac
t 1.25 mg/ml  (Table 1). FMC3 and FMC4 showed a decrease of
.8% ± 1.5 and 7.7% ± 2.6, respectively, at 2.5 mg/ml. However nei-
her alginate showed a signiﬁcant affect at the other concentrations
ested. FMC  7 showed signiﬁcant inhibition at 5 and 2.5 mg/ml  of
.3% ± 2.9 and 5.6% ± 0.8, respectively, however showed no signif-
cant affect at 1.25 mg/ml.], (e) F[MGM], and (f) n(G > 1) the G-block length against level of pepsin inhibition
. The error bars show the standard deviation of six replicates (n = 6).
3.2. pH dependent alginate–protein interactionsIn the control alginate solution the samples showed behaviour
typical of a pH dependent gel with speciﬁc viscosity increasing at
lower pH’s as an acid gel was  formed. Addition of BSA or casein to
the mixture caused a visible precipitate to form in samples titrated
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lig. 3. (a–c) pH dependent viscosity interaction of alginates with BSA (10 mg/m
eight = 397,000, (b) LFR560 (2.5 mg/ml) molecular weight = 34,700, (c) SF200 (2.5 
o acidic pH, but not in samples at neutral pH. From the pH depend-
nt speciﬁc viscosity plot of H120L and BSA/Casein in Fig. 3a, at a
H around neutral there was little or no difference in viscosity of
upernatant with the addition of BSA or casein. However in the sam-
les with BSA and casein present, at lower pHs the viscosity of the
upernatant approached zero as a precipitate had formed between
lginate and the protein which has settled to the bottom of the tube,
ringing the viscous alginate component out of solution.
Four alginates were tested in this way. SF120L behaved in a simi-
ar manner as H120L (data not included). As can be seen from Fig. 3b, casein (10 mg/ml) across the pH range (n = 3). (a) H120L (2.5 mg/ml) molecular
l) molecular weight = 387,000.
LFR560 had a maximum speciﬁc viscosity of between 3 and 4 as
compared to the other alginates with maximum speciﬁc viscosities
in the range 15–45. This is due to LFR560 being a low molecular
weight alginate (34,700 Da) as compared to alginates H120L, SF120
and SF200 with molecular weights up to an order of magnitude
larger (195,000–397,000).In all samples the same formation of precipitate and lower
supernatant viscosity was observed. In the case of SF200, at neutral
pH the addition of BSA and casein to the mixture caused an approx-
imate doubling of supernatant viscosity suggesting a synergistic
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Fig. 4. Bovine serum albumin digestion in gastric phase of a model gut system with and without SP54. The graph shows total protein recovered from model gut system after
TCA  (trichloroacetic acid) precipitation to stop enzyme activity and remove undigested polypeptides. 0.5 g BSA was digested alone (control digestion) and in the presence
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gf  varying concentrations of SP54. Control digestion is represented as () and dige
riplicate, errors are shown as standard deviation. At T[60] by the end of the gastric
igestion of protein by 54.1% (P = 0.0001), 78.9% (P = 0.001) and 87.6% (P = 0.0004), r
nteraction between alginate SF200 and protein at neutral pH
Fig. 3c). The interaction between SF200 and BSA/casein at lower
H was consistent with the other tested samples.
LFR560 was the only sample in which the sample retained some
f its viscosity at low pH after the addition of BSA, this suggests that
here is an interaction by which some alginate remains. This result
ay  indicate a size-dependent interaction between BSA and algi-
ate, although LFR560 was the only low molecular weight alginate
vailable for testing.
.3. Protein digestion in the model gut.3.1. Gastric protein digestion
Pentosan polysulphate (SP54) was used as the positive inhibi-
ion control. At all tested concentrations of 50, 100 and 200 mg
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ig. 5. Bovine serum albumin digestion in gastric phase of a model gut system with and 
ystem  after TCA (trichloroacetic acid) precipitation to stop enzyme activity and remove u
resence of varying concentrations of FMC13. Control digestion is represented as as () a
ere  tested in triplicate, errors are shown as standard deviation. At T[60] by the end of th
astric  digestion of protein by 23.4% (P = 0.021), 52.2% (P = 0.040) and 43.5% (P = 0.013), reith SP54 at 125 mg as (), 250 mg () and 500 mg (). All samples were tested in
, 125, 250 and 500 mg of pentosan polysulphate signiﬁcantly inhibited the gastric
ively (t-test).
pentosan polysulphate there was signiﬁcant inhibition of gastric
proteolysis at all time points from T[5] onwards (Fig. 4) At T[5],
50, 100 and 200 mg  of pentosan polysulphate signiﬁcantly inhib-
ited the gastric digestion of protein by 62.5% (P = 0.005), 90.1%
(P = 0.003) and 90.5% (P = 0.002), respectively. At T[60] by the end
of the gastric phase, 50, 100 and 200 mg  of pentosan polysul-
phate signiﬁcantly inhibited the gastric digestion of protein by
54.1% (P = 0.0001), 78.9% (P = 0.001) and 87.6% (P = 0.0004), respec-
tively.
Four alginates from across the F[G] range were tested, and all
FMC3, FMC13, SF120 and H120L produced signiﬁcant inhibition of
protein digestion in the gastric phase. By the end of the simulated
gastric phase, FMC13 was  the weakest of the four alginates tested
(Fig. 5). By T[60] after an hour of simulated digestion with 125, 250
and 500 mg of FMC13, proteolytic digestion was reduced by 23.4%
40 50 60 70
 (min)
without FMC13 alginate. The graph shows total protein recovered from model gut
ndigested polypeptides. 0.5 g BSA was  digested alone (control digestion) and in the
nd digestion with FMC13 at 125 mg as (), 250 mg  ()  and 500 mg  (). All samples
e gastric phase, 125, 250 and 500 mg of FMC13 alginate signiﬁcantly inhibited the
spectively (t-test).
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Fig. 6. Bovine serum albumin digestion in gastric phase of a model gut system with and without FMC3 Alginate. The graph shows total protein recovered from model gut
system  after TCA (trichloroacetic acid) precipitation to stop enzyme activity and remove undigested polypeptides. 0.5 g BSA was digested alone (control digestion) and in
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ere  tested in triplicate, errors are shown as standard deviation. At T[60] by the en
astric digestion of protein by 52.8% (P = 0.004), 70.9% (P = 0.001499) and 73.06 (P =
P = 0.021), 52.2% (P = 0.04) and 43.5% (P = 0.013), respectively, as
ompared to a control.
At timepoints T[30] and T[45] there was a larger percentage inhi-
ition as compared to control. At T[30] with 125, 250 and 500 mg
f FMC13 proteolytic digestion was reduced by 52.8% (P = 0.004),
5.7% (P = 0.004) and 62.7 (P = 0.001), respectively. At T[45] after
5 min  of simulated digestion with 125, 250 and 500 mg  of FMC13
roteolytic digestion by 52.8% (P = 0.004), 70.9% (P = 0.002) and
3.06 (P = 0.018).
FMC3 showed a similar inhibition proﬁle to FMC13 (Fig. 6). At
[30], protein digestion was reduced by 51.9% (P = 0.0002), 69.6%
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ig. 7. Bovine serum albumin digestion in gastric phase of a model gut system with and
ystem after TCA (trichloroacetic acid) precipitation to stop enzyme activity and remove
he  presence of varying concentrations of SF120. Control digestion is represented as as (
ere  tested in triplicate, errors are shown as standard deviation. At T[60] by the end of th
astric digestion of protein by 32.9% (P = 0.0025), 30.8% (P = 0.007) and 50.5% (P = 0.001), r) and digestion with FMC3 at 125 mg as (), 250 mg () and 500 mg  (). All samples
he gastric phase, 125, 250 and 500 mg of FMC3 alginate signiﬁcantly inhibited the
46) respectively (t-test).
(P = 0.013) and 48.0% (P = 0.016) with 125, 250 and 500 mg  of
FMC3 alginate, respectively. At T[45], protein digestion was  reduced
by 50.4% (P = 0.005), 64.0% (P = 0.015) and 47.2% (P = 0.0004) as
compared to control with 125, 250 and 500 of FMC3 alginate,
respectively. By the ﬁnal timepoint at T[60], protein digestion was
reduced by 20.2% (P = 0.029), 64.8% (P = 0.024) and 55.1% (P = 0.035)
as compared to control with 125, 250 and 500 mg of FMC3 alginate,
respectively.
With SF120 at T[15], the highest levels of inhibition were
achieved with the highest concentration of 500 mg  SF120 (Fig. 7).
At T[30], protein digestion was  reduced by 35.4% (P = 0.010), 47.3%
40 50 60 70
 (min)
 without SF120 alginate. The graph shows total protein recovered from model gut
 undigested polypeptides. 0.5 g BSA was digested alone (control digestion) and in
) and digestion with FMC3 at 125 mg as (), 250 mg () and 500 mg (). All samples
e gastric phase, 125, 250 and 500 mg of SF120 alginate signiﬁcantly inhibited the
espectively (t-test).
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Fig. 8. Bovine serum albumin (BSA) digestion in the small-intestinal phase of a model gut system with and without SBTI. The graph shows total protein recovered from model
gut  system after TCA (trichloroacetic acid) precipitation to stop enzyme activity and remove undigested polypeptides. 1 g BSA was digested alone (control digestion) and in
the  presence of varying concentrations of SBTI. Control digestion is represented as as () and digestion with SBTI at 125 mg as (), 250 mg  () and 500 mg  (). All samples
were  tested in triplicate, errors are shown as standard deviation. With 500 mg SBTI, from T[75] until T[180] inhibition of proteolytic activity was between 90.6 and 100% and
statistically signiﬁcant at all time-points (p < 0.05). With 250 mg SBTI, statistically signiﬁcant inhibition of over 60.1% was achieved at all timepoints after T (p < 0.05). With
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t25  mg  of SBTI, statistically signiﬁcant inhibition of proteolytic digestion was achie
[180] the reduction in protein digestion relative to control could not be shown to be
P = 0.033) and 62.1% (P = 0.002) as compared to control with 125,
50 and 500 mg  of SF120 alginate, respectively. At T[45], pro-
ein digestion was reduced by 60.8% (P = 0.003), 37.5% (P = 0.003)
nd 70.2% (P = 0.019) with 125, 250 and 500 mg  of SF120 algi-
ate respectively. By the ﬁnal timepoint at T[60], protein digestion
as reduced by 32.9% (P = 0.0025), 30.8% (P = 0.007) and 50.5%
P = 0.001) with 125, 250 and 500 mg  of SF120 alginate, respectively.
At higher concentrations of alginate H120L (250 and 500 mg)
here was a signiﬁcant increase in the rate of protein digestion at
[5], and with 500 mg  an increase also at T[10] (data not shown). At
[5] there was an increase in protein digestion of 71.8% with 250 mg
120L and of 154% with 500 mg,  although neither of these increases
ere statistically signiﬁcant. At T[10] there was an increase in the
igested protein yield of 145% with 500 mg  H120L, which was  sta-
istically signiﬁcant (P = 0.038). From T[30] onwards the data for
120L follows a similar trend to what was seen with the other algi-
ate samples, whereby there is a reduced level of protein digestion
t all timepoints for all alginates.
.3.2. Pancreatic phase protein digestion
Fig. 8 shows a control digestion of 1 g of BSA in the model gut
ystem with soybean trypsin inhibitor (SBTI) was used as the pos-
tive inhibition control. Three concentrations of SBTI were tested
n the model gut in order to validate the detection of inhibition of
roteolysis. The addition of SBTI to the digestive mixture reduced
roteolytic activity and reduced the amount of digested protein
ecovered from the assay in the small intestinal phase. From T[70]
nwards the addition of 250 and 500 mg  yielded statistically signiﬁ-
ant inhibition at all timepoints until the end of the assay. Inhibition
evels of 23%, 75% and 100% were observed with 125, 250 and
00 mg  of SBTI.
Four alginates were tested for their effects on protein digestion
n the small-intestinal phase of the model gut system. While there
ere variations in levels of protein digestion with the addition of
lginate, none of these deviations from the relative control time-
oint could be shown to be statistically signiﬁcant (data not shown).
. DiscussionAlginates have been shown to have the ability to modify the
ctivity of multiple digestive enzymes in vitro and affect the diges-
ion proﬁle of major macronutrients. Some of these functional[70]
etween T[70] and T[120] ranging from 59.25 to 100% (p < 0.05), however at T[150] and
stically signiﬁcant.
effects have been shown to be linked to structural characteristics of
alginates (Sunderland et al., 2000; Wilcox, 2010; Wilcox, Brownlee,
Richardson, Dettmar, & Pearson, 2014).
Through the use of an N-terminal proteolysis assay it was  pos-
sible to determine that alginate was  a potent inhibitor of pepsin
activity, but had no signiﬁcant inhibitory effect on trypsin.
The high F[M] alginate H120L reduced pepsin activity to the
highest extent and it was  shown that the potency of inhibition
correlated with alginate structure. A strong positive correlation
between alginate F[M] and levels of pepsin inhibition, supported
the ﬁndings of Strugala et al. (2005). And we have shown that
an increasing proportion of contiguous G-blocks was  shown to
be negatively associated with inhibition of pepsin; [n(G > 1)],
F[GG] and F[GGG] all negatively correlating with pepsin inhibi-
tion.
Only a small number of the tested alginate samples were
observed to have had a statistically signiﬁcant inhibition of trypsin.
The catalytic mechanisms of pepsin and trypsin are distinct, it is
therefore possible that alginate is able to interact with and disrupt
the catalytic mechanism of pepsin, but not of trypsin. Pepsins are
aspartate proteases, and broad speciﬁcity endopeptidases with a
preferance for cleavage between hydrophobic amino acids (Powers,
Harley, & Myers, 1977). Trypsin on the other hand is a serine
protease. Serine proteases are usually endopeptidases and pref-
erentially cleave within the poplypeptide chain, prefererentially
cleaving on the carboxyl side of lysine and arginine (Hedstrom,
2002a, 2002b).
In pepsin mediated proteolysis, the two  aspartate residues
(Asp32 and 215 in pig pepsin) form an acid base pair in the active
site cleft, holding a water molecule which facilitates nucleophillic
attack on the peptide bond. The extensive hydrogen bonding net-
work is required to maintain the basic Asp32 in the COO− state.
Nucleophillic attack by the water molecule on the peptide bond
NH–CO generates –NH2 and –COOH (Szecsi, 1992).
Looking at the mechanism of other pepsin inhibitors can be
instructive of how alginate may  inhibit pepsin inhibition. Pep-
statin is a linear peptide inhibitor of aspartic proteases including
pepsin, it is a competitive pepsin inhibitor which blocks the active
site by forming a network of hydrogen bonds and charge–charge
interactions with active-site residues (El Aouad et al., 2011). The
inhibitor complexes with the enzyme and prevents substrate bind-
ing (Fujinaga, Chernaia, Tarasova, Mosimann, & James, 1995).
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Mannuronic and guluronic acid residues are rich in hydroxyl
roups which would be capable of forming hydrogen bond interac-
ions with these same active site residues. The formation of these
ydrogen bonds is likely to rely on the ﬂexibility of the alginate
hains in solution and the report (Smidsrod & Skjak-Braek, 1990)
hat GG rich alginates are the least ﬂexible and MG  rich the most
ould explain why GG rich alginates are the worst inhibitors. Fur-
hermore the C O group of the carboxyl group is able to participate
n hydrogen bonding, and to a lesser extent form charge–charge
nteractions.
The idea of a direct inhibitory interaction between alginate and
epsin was also argued by Sunderland et al. (2000) who  showed
n an alginate–pepsin centrifugation experiment that pepsin was
ulled out of the solution by alginate upon centrifugation. This
uggested direct binding of pepsin as a possible mechanism of inhi-
ition.
Carboxyl groups have been shown to be important in the inhi-
ition of lipase by pectin. This provides an example of how alginate
ay  inhibit pepsin activity directly (Isaksson, Lundquist, & Ihse,
982). The carboxyl groups of pectin are believed to be involved in
he protanation of active site serine residue of the lipase enzyme.
he protonation of the hydroxyl group of serine blocks the initia-
ion of this charge relay system, thereby inactivating the enzyme
Wilcox, 2010). The importance of carboxyl groups to pectin inhi-
ition of lipase has been shown as increasing levels of methyl
steriﬁcation are correlated with reduced lipase inhibition. As it is
he carboxyl group that becomes esteriﬁed, an increase in methyl
steriﬁcation necessarily means a decrease in the number of car-
oxyl groups. Similar to pectins, alginates are rich in carboxylic acid
roups.
Lipase and trypsin share similar active site mechanisms and sim-
lar pH optima, however alginate is able to inhibit the action of
ancreatic lipase, but not trypsin. All trypsin enzymes have a neg-
tively charged substrate binding pocket, and bind basic positively
harged amino acids. As alginates are large negatively charged poly-
ers, they would be repelled from the trypsin substrate binding site
ue to charge:charge repulsion and have poor accessibility to the
ctive site binding pocket due to size (Katona, Berglund, Hajdu, &
raaf, 2002). While trypsin binding sites and alginate would both
e negatively charged at pH 7.0, at pH 2.0 alginate would be mainly
ncharged due to protonation of the carboxyl groups, allowing the
otential for the hydrophobic faces of the sugar rings to inter-
ct with the hydrophobic binding pocket of pepsin. This may  be
 reason why alginate inhibits pepsin and lipase activity without
ffecting trypsin.
The residues of the catalytic triad are spread across the active
ite cleft. With Ser195 on one side and Asp102 and His57 on the
ther (Hedstrom, 2002a, 2002b). With the substrate co-ordinated
n place by forming an anti-parallel beta-sheet across the protein
inding site, the electronegatively charged base His57 can act to
ccept the hydrogen from the hydroxyl group of Ser195. This allows
er195 to act as a nucleophile, attacking the carbonyl carbon of the
eptide bond, forming an acyl-enzyme intermediate with the sub-
trate (Polgar, 2005). The carbonyl carbon is + as a dipole is formed
ver the C O bond with the electrons pulled towards the elec-
ronegative oxygen, leaving the carbon susceptible to nucleophillic
ttack from serine.
SBTI inhibits trypsin activity by strongly binding across the
ctive site and blocking substrate binding with Arg63′-Ile64′ of SBTI
imicking the scissile peptide bond with the positively charged
rg63′ occupying the primary speciﬁcity pocket of trypsin (Blow,
anin, & Sweet, 1974). Evidently, as a polysaccharide, an alginate
olecule would not be able to mimic  binding of a protein substrate.
Due to the distinctly different inhibition proﬁles for pepsin and
rypsin, the manner in which alginates and protein substrates inter-
ct across the pH range was investigated viscometrically. Profoundlymers 131 (2015) 142–151
interactions between alginate and protein were observed at acidic
pHs, but no pattern of interaction was  observed at neutral pH; with
all alginate samples tested, a protein–alginate co-precipitate was
formed at acidic pH, but not at a neutral pH.
SP54, heparin sulphate, and other highly sulphated polysaccha-
rides are known to inhibit pepsin activity (Bianchi & Cook, 1964;
Cook & Drill, 1967) and protein–carbohydrate interactions are com-
mon  in biology, and widely reported in vitro (Dickinson, 1998).
Interactions between casein and carrageenans have been observed
due to electrostatic interactions forming between the sulphate
groups of carrageenan and positively charged regions of the casein
polymer (Grindrod & Nickerson, 1968; Payens, 1972). As the pH
is lowered, protein is taken below its iso-electric point, resulting
in a loss of negative charges and formation of positive charges. The
positively charged protein can then form interactions with negative
charges on the carbohydrate and carbohydrate–protein complexes
form, leading to precipitation (De Jong & Hubertus, 2008). This non-
speciﬁc protein binding raises the possibility that in addition to
interactions at the active site, non-speciﬁc inhibitor–substrate and
inhibitor–enzyme interactions could be involved in pepsin inhibi-
tion.
Alginate is a negatively charged polymer, and as such would
be capable of forming electrostatic interactions with proteins that
have become positively charged after being taken below their pKa
(Then et al., 2012). Alginate may  associate with protein through
hydrogen bonding at hydroxyl groups; charge–charge interactions
with -carboxyl groups and the negatively charged COO– group of
the alginate, although this group would become protonated at low
pH. As with the carrageenan–casein interactions, these reactions
would be sensitive to structure, pH, concentration and levels of
counter-ions.
As alginates can form acid gels in the presence of gastric
contents, it is important to consider if the inhibition of pepsin
would be altered between alginate in solution or as a gel. If the
levels of inhibition are compared with alginate in solution using
the N-terminal proteolytic assay and the model gut containing all
the pertinent gastric secretions, they are found to be similar. This
indicates that if alginate comes out of solution, it can still inhibit,
presumably by trapping substrate and enzyme in the gel, and by any
alginate remaining solubilised inhibiting by binding to the enzyme
or substrate.
5. Conclusions
The observation of a pH dependent interaction between alginate
and protein suggests a possible mechanism by which alginate may
prevent the action of pepsin without effecting trypsin in a similar
way. The binding of alginate to protein at low pH and formation
of a precipitate would remove protein from solution and make the
substrate unavailable to pepsin. However, this precipitation inter-
action did not occur at neutral pH and therefore substrate remains
available for trypsin digestion, this explains why  little evidence of
trypsin inhibition was observed.
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